FTC Says Pharmacy Antitrust Amnesty Will Hurt Competition
A proposed law that would exempt independent pharmacies from antitrust laws and allow them to collectively negotiate with health plans would harm competition and raise the cost of prescription drugs for...To view the full article, register now.
Already a subscriber? Click here to view full article